Feifei Gu
Impact in
-
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 6
-
- Cancer-related molecular mechanisms research 2
- Co-authors
- Jinyan Liang (15 shared papers)Li Liu (13 shared papers)Kai Zhang (11 shared papers)Yangyang Liu (6 shared papers)Yulan Zeng (12 shared papers)Yuanliang Huang (2 shared papers)Xiaohua Hong (4 shared papers)Qifan Yang (9 shared papers)
In The Last Decade
Feifei Gu
29 papers receiving 402 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 78
- Oncology 130
- Immunology 79
- Pulmonary and Respiratory Medicine 95
- Pharmacology 17
Countries citing papers authored by Feifei Gu
This map shows the geographic impact of Feifei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Gu more than expected).
Fields of papers citing papers by Feifei Gu
This network shows the impact of papers produced by Feifei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Gu. The network helps show where Feifei Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 86 | |
| 2 | 2017 | 36 | |
| 3 | 2016 | 31 | |
| 4 | 2017 | 30 | |
| 5 | Relationship between plasma cathepsin S and cystatin C levels and coronary plaque morphology of mild to moderate lesions: an in vivo study using intravascular ultrasound. | 2009 | 26 |
| 6 | Icariside II promotes osteogenic differentiation of bone marrow stromal cells in beagle canine. | 2015 | 24 |
| 7 | 2019 | 19 | |
| 8 | 2020 | 18 | |
| 9 | 2020 | 17 | |
| 10 | 2020 | 16 | |
| 11 | 2017 | 15 | |
| 12 | 2016 | 12 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 10 | |
| 15 | 2019 | 9 | |
| 16 | 2019 | 8 | |
| 17 | 2022 | 7 | |
| 18 | 2022 | 6 | |
| 19 | 2017 | 5 | |
| 20 | 2023 | 4 |
About Feifei Gu
Feifei Gu is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Pharmacology, having authored 30 papers that have together received 408 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (5 papers), Immune Cell Function and Interaction (4 papers), Ferroptosis and cancer prognosis (3 papers), RNA modifications and cancer (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer-related molecular mechanisms research (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Cancer Research (78 citations), Oncology (130 citations), Immunology (79 citations), Pulmonary and Respiratory Medicine (95 citations) and Pharmacology (17 citations). Feifei Gu has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Jinyan Liang, Li Liu, Kai Zhang, Yangyang Liu, Yulan Zeng, Yuanliang Huang, Xiaohua Hong, Qifan Yang, Yue Hu and Yangyang Liu. Their work appears in journals such as Journal of Hematology & Oncology, Medicine, Frontiers in Immunology, Measurement and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.